Paraguay Dengue Watch: Paraguay’s Ministry of Public Health reports dengue remains stable, averaging 102 notifications per week, with only three new confirmed cases in SE 25–27 and no recent hospitalizations or deaths; cumulative cases reached 288 as of July 18, with DENV-1 identified and the Limpio outbreak showing a sharp decline. Neurology Burden in the Americas: A new Lancet Regional Health—Americas study says nearly 470 million people in the region (about 2 in 5) live with neurological disorders, shifting the burden from premature death toward long-term disability—raising demand for prevention, rehabilitation, and long-term care. Paraguay’s Investment-Grade Signal: Moody’s reaffirmed Paraguay’s Baa3 investment-grade rating with a stable outlook, citing credible monetary policy and political stability. Maquila Jobs and Exports: Paraguay’s maquila exports hit US$717 million in the first half of 2026, up 25% year-on-year, creating 1,923 new jobs, led by automotive parts, clothing, and chemical products. Health & Safety Abroad (Crowding): U.S. ICE emails describe dangerous overcrowding and inadequate medical support at a New York detention site, including people with serious conditions left without proper care. Kidney Drug R&D: Dimerix says it has expanded its kidney pipeline, adding an acute kidney injury program tied to heart surgery patients, alongside its phase III FSGS study.